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13.1 INTRODUCTION
Modern approaches aimed at studying physiological and pathological processes in living systems require applications of
physical techniques that can provide information at the molecular level. M€ ossbauer spectroscopy was already used for
investigating biological materials a few years after the discovery of Rudolf M€ ossbauer. The development of biological
applications paved the way for further applications of M€ ossbauer spectroscopy in medical research. Therefore, the term
“biomedical” can be considered both from a broader viewpoint, which means all possible aspects of biological research,
and from a narrower viewpoint, which means any biological, biophysical, and biochemical research related to medical
problems (normal and pathological physiology, environmental factors and health, medicine and pharmaceutics, etc.) [1].
In this chapter, the latter meaning of the term “biomedical research” will be used, in addition to biological studies.
Up to now, several thousand paperson various biological aspects ofM€ ossbauer spectroscopy applications havebeen
published (for some previous reviews see, for instance, Refs. 2–12), while only about 350–400 articles can be considered
as biomedical from the narrower viewpoint (for reviews see Refs. 13–25). These studies were based mainly on
57Fe-containing subjects; however, in a number of cases, 57Co, 119Sn, 129I, 153Sm, 161Tb, and 197Au containing species
were used. Various objects, from molecules to tissues and organs, were studied in normal physiological conditions and in
the case of pathologies.
In this chapter, some recent examples of biology-related and biomedical applications of M€ ossbauer spectroscopy are
considered, including studies related to microorganisms, plants, iron-containing biomolecules, tissues, and pharmaceutical
products. Attention is also paid to different M€ ossbauer techniques involving the usual transmission geometry (emission
experiments recently discussed in Refs. 26–30 will be reviewed separately [31]) and newly developed M€ ossbauer
spectroscopywithahighvelocityresolution[32,33].TheﬁrstresultsofbiomedicalapplicationsofM€ ossbauerspectroscopy
with a high velocity resolution were reviewed in Refs. 34–39 and are brieﬂy considered within this chapter, while
applications of M€ ossbauer spectroscopy using synchrotron radiation were recently reviewed in Refs. 12,40.
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13.2 MICROORGANISMS-RELATED STUDIES
Microorganisms in soil and aquifers are well documented to be actively involved in a range of biogeochemical processes
leading to biomineralization and in a diversity of chemical transformations of soil minerals. Fe(III), largely represented by
extremelypoorlywater-solubleoxyhydroxidesofvariablecrystallinity,isanessentialcomponentofmanysoilminerals.A
variety of soil bacteria were reported to couple oxidation of soil organic matter, including organic pollutants, to
dissimilatory reduction of many redox-active metals, primarily Fe(III) and Mn(IV) [41].
Besides the above-described directly biotic reduction of Fe(III) by microbial cells, a range of secondary metabolites,
produced both by soil microorganisms and by plant roots and excreted into the environment, can abiotically reduce Fe
(III). Some earlier and more recent experiments using 57Fe M€ ossbauer spectroscopy have shown that such biologically
and environmentally important low molecular weight organic substances as anthranilic (o-aminobenzoic) acid [42,43],
indolic compounds including tryptophan, indole-3-acetic acid (IAA, a phytohormone of the auxin series produced by
many soil microorganisms), and other auxins [44–50], cysteine (e.g., adsorbed on clay) [51], and so on, can abiotically
reduce Fe(III) in weakly acidic media (under pH 4–5) even under aerobic conditions.
Note that in the case of tryptophan, no Fe(III) reduction was observed within 15 min after mixing the reagents even
at pH  2 [46], while the resulting Fe(II) had earlier been detected in M€ ossbauer spectra after longer periods [49,50]. In
particular, partial reduction of Fe(III) to Fe(II) was detected by M€ ossbauer spectroscopy in the course of synthesis of
ferric complexes with tryptophan and lysine, which included the procedures of precipitation and extraction with
nonaqueous solvents [49].
Gradual Fe(III) reduction to Fe(II) by a series of auxins (indole-3-alkanoic acids with C1–C4 side chains) in weakly
acidic aqueous solutions was evident from M€ ossbauer spectroscopic measurements [46,47] performed in rapidly frozen
solutions after 15min and 2 days of reaction at ambient temperature (Fig. 13.1). In that case, rapid freezing allows all the
ongoing processes to be ceased at a certain time point, and M€ ossbauer measurements in the solidiﬁed frozen matrix
become feasible.
Already 15min after mixing 57FeðIIIÞ salt solution with that of an organic acid, high-spin Fe(II) was readily detectable
in the spectra of ﬁltered and frozen solutions by its characteristic quadrupole doublet with a large value of quadrupole
splitting. After 2 days under those conditions, Fe(II) dominated in all the solutions, except for indole-3-carboxylic acid
(ICA) (see Fig. 13.1e) for which the reduction rate was deﬁnitely lower than that for the other indolic acids studied. In all
the cases (see Fig. 13.1), the Fe(II) quadrupole doublets gave the following parameters: isomer shift (d),  1.40mm s
 1
FIGURE 13.1
M€ ossbauer spectra of mixed
57FeðIIIÞ nitrate and indole-3-
alkanoic acid aqueous solutions
(molar ratios 1:3; initial
57FeðIIIÞ
concentration 0.01M) ﬁltered
and rapidly frozen (at T¼80K)
15min (a–d) and 2 days (e–h)
after mixing the reagents (ﬁnal
pH  3). Acids used: (a), (e)—ICA;
(b), (f)—IAA; (c), (g)—indole-3-
propionic acid (IPA); (d), (h)—
indole-3-butyric acid (IBA). The
position of the components
related to Fe(II) (shaded areas) is
shown in the upper plots by
square brackets. (Adapted from
Refs. 46, 47.)
13.2 MICROORGANISMS-RELATED STUDIES 273CH13 07/04/2013 8:10:49 Page 274
(here and further d for 57Fe are given relative to a-Fe at 295K); quadrupole splitting (DEQ), 3.3mms
 1 (at T¼80K),
which corresponds to ferrous hexaaquo complex [52]. Thus, the reduced iron ions in the solutions were most probably
in the hydrated form not coordinated to the acids or their oxidation products.
It is noteworthy that for indole-3-acetic acid, a virtually full reduction was observed within 2 days (see Fig. 13.1f),
which corresponds to its more easily proceeding oxidative decarboxylation [41]. However, after drying the mixture in
air, all the Fe(II) was found to get reoxidized back to Fe(III) [44]. This effect, under appropriate soil conditions (acidic
medium, varying humidity), could give rise to a cycling process facilitating oxidative degradation of IAA in soil in the
presence of Fe(III) [44,45]. Since acidic soils are rather widely distributed, besides highly metal-polluted soils that often
have lower pH [41], such abiotic Fe(III) reduction involving organic molecules of biotic origin may signiﬁcantly contribute
to iron transformation in soil [41,49].
Another representative ecologically important example of Fe(III) redox interaction with microbially produced
extracellular biomolecules involves alkylresorcinols with short alkyl side chains—microbial signaling molecules that have
been documented to perform autoregulatory and adaptogenic functions under unfavorable conditions and show other
remarkably diverse biochemical and physiological activities [53]. In aqueous mixtures of 5-methylresorcinol and 57FeðIIIÞ
salt at ﬁnal pH  3, the appearance of Fe(II) was clearly detectable by M€ ossbauer spectroscopy (at 80K) already in a few
FIGURE 13.2
M€ ossbauer spectra of
57FeðIIIÞ-containing aqueous solutions (a) of 5-methylresorcinol (orcinol) rapidly frozen 10min
and (b) 5.5h after mixing (ﬁnal pH  3), as well as of (c) the solid residue obtained by air-drying the mixture at room
temperature; (d) of
57FeðIIIÞ-containing aqueous (20% (v/v) ethanol) solution of 4-n-hexylresorcinol rapidly frozen
5min after mixing (ﬁnal pH  3) and (e) of the solid residue obtained by air-drying the mixture at room temperature
(initial molar Fe-to-alkylresorcinol ratios 1:3; initial
57FeðIIIÞ concentration 0.016 M); all spectra measured at T¼80K.
The shaded areas (quadrupole doublets) represent contributions of Fe(III) (the most lightly shaded area) or Fe(II)
(darker shaded areas) to the whole spectrum area (deﬁned by the outer solid-line envelope); in spectra (c) and (e),
the two and three darker-shaded areas, respectively, correspond to two different Fe(II) forms (see Table 13.1). The
position of each quadrupole doublet is shown by a square bracket above the spectra, with indication of the
corresponding Fe oxidation state. (Adapted from Ref. 53.)
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minutes (Fig. 13.2a), while its gradual accumulation was evident within a few hours after mixing (Fig. 13.2b; all the
M€ ossbauer parameters evaluated from the spectra are listed in Table 13.1). The parameters of the ferrous species
formed upon Fe(III) reduction in the solutions (in particular, d  1.4mm s
 1; DEQ 3.2mms
 1 at T¼80K) most closely
correspond to hexaaquo Fe(II) coordination [52,54].
Drying the mixture of 5-methylresorcinol and Fe(III) in air under ambient conditions led to the resulting dried solid
that gave a more complicated M€ ossbauer spectrum (Fig. 13.2c), with two different forms of Fe(II) species (altogether
comprising over three-fourth of the total iron), along with a residual ferric form (see Table 13.1). The parameters of the
two ferrous forms evidently represent different complexes of Fe(II) with the possible residuary 5-methylresorcinol and/
or its oxidation product(s) that might include 1,2,3-trihydroxy- and/or 1,3,4-trihydroxy-5-methylbenzenes, or the
relevant hydroxylated quinones [53]. Thus, those M€ ossbauer measurements, in line with the UV spectroscopic
monitoring of the soluble products [55], provide clear evidence that Fe(III) is gradually reduced by 5-methylresorcinol
in moderately acidic (pH  3) aqueous solutions in air.
Interestingly,underthesameconditions,4-n-hexylresorcinolshowedasigniﬁcantlyhigherFe(III)reductionrate.Already
5min after mixing the reagents, about a third of the total Fe(III) was reduced to Fe(II) represented by a quadrupole doublet
with the parameters typical for hexaaquo Fe(II) complex (Fig. 13.2d; see also Table 13.1). As Fe(III) ions at pH  3 are well
known to be prone to hydrolytic polymerization, in this case the residual Fe(III), which gives virtually the same M€ ossbauer
parametersasthosefortheaqueous5-methylresorcinolsolution10minaftermixing,represents,mostprobably,hydrolyzed
polymeric and/or colloidal hydroxo species [52]. Note that some participation of the organic molecules or their oxidation
products in Fe(III) coordination cannot be ruled out merely on the basis of Fe(III) M€ ossbauer parameters.
After similarly drying the mixture of 4-n-hexylresorcinol and Fe(III) in air under ambient conditions, the resulting
dried solid gave a yet more complicated M€ ossbauer spectrum, with three different forms of ferrous species (altogether
comprising ca. two-third of the total iron), along with a residual ferric form (Fig. 13.2e; see also Table 13.1). The
parameters of the ferrous forms in the dry residue, except probably for form 3 (which are rather close to those for
hydratedFe
2þionsinsolidferrous chloridehydratesatT 80K[52]), evidently correspondtodifferentFe(II) complexes
with the possible residuary 4-n-hexylresorcinol and/or its oxidation product(s). However, note that these parameters
and, consequently, the Fe
2þ microenvironments (i.e., type and arrangement of donor atoms in the ligands) differ from
thoseforthedried5-methylresorcinolsolution(see aboveandTable 13.1). Differentpositions ofthe alkyl substituentsin
the 1,3-dihydroxybenzene (i.e., resorcinol) moieties might be expected to lead to different oxidation products of the
TABLE 13.1 M€ ossbauer Parameters for
57FeðIIIÞ-Containing Aqueous Solutions of 5-Methylresorcinol and 4-n-
Hexylresorcinol (Containing 20% (v/v) Ethanol; see also Fig. 13.2) at pH 3 (Total [Fe]¼16 1mM;
1:3 Fe-to-Alkylresorcinol Molar Ratios), Rapidly Frozen After Speciﬁed Periods of Time, and for Their
Solid Residues Obtained by Drying in Air at Ambient Temperature (Measured at T¼80K) [53]
Alkylresorcinol
Mixed with 57FeðIIIÞ in
Solution (Sample Measured) Time
a Fe Oxidation State d
b, c (mm s
 1) DEQ
c, d (mm s
 1) Gexp
c, e (mm s
 1)S
f (%)
5-Methylresorcinol (solution) 10min þ3 0.48(1) 0.74(1) 0.52(1) 93.3
þ2 1.41(1) 3.22(1) 0.34(1) 6.7
5.5h þ3 0.48(1) 0.72(1) 0.50(1) 74.1
þ2 1.38(1) 3.23(1) 0.42(1) 25.9
5-Methylresorcinol (dried solid)– þ3 0.48(1) 0.63(2) 0.43(2) 24.5
þ2( form 1) 1.31(1) 1.86(3) 0.50(3) 33.3
þ2( form 2) 1.29(1) 2.65(1) 0.34(1) 42.2
4-n-Hexylresorcinol (solution) 5min þ3 0.475(3) 0.757(4) 0.49(1) 68.8
þ2 1.402(3) 3.388(5) 0.34(1) 31.2
4-n-Hexylresorcinol (dried solid)–þ3 0.54(1) 0.65(1) 0.48(2) 34.9
þ2( form 1) 1.43(1) 1.55(3) 0.35(3) 9.0
þ2( form 2) 1.29(1) 2.54(2) 0.45(3) 23.7
þ2( form 3) 1.359(3) 3.10(1) 0.34(1) 32.4
aPeriod from mixing the reagents until rapid freezing of the solution.
bIsomer shift (relative to a-Fe at ambient temperature).
cErrors (in the last digits) obtained from the ﬁts are given in parentheses.
dQuadrupole splitting.
eFull line width at half maximum.
fRelative SD are within ca.  4%.
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5-and4-alkylsubstitutedresorcinols[55].Thisfactor,possiblytogetherwiththelengthofthealkylgroup,mightbeareason
forthesigniﬁcantdifferenceintheFe(III)reductionrateobservedfor5-methyl-(i.e.,5-C1-alkyl;agradualredoxprocess)and
4-n-hexyl-substitutedresorcinol(4-n-C6-alkyl;amuchmorerapidredoxprocess).SimilartrendsofFe(III)reductioningoing
from the autoinducer solutions to their air-dried solids have also been obtained at slightly lower pH  1.5 [53].
The redox behavior of Fe(III) mixtures with both alkylresorcinols [53,55] upon drying was totally different from that
of indole-3-acetic acid (auxin) aqueous solutions studied earlier [44,45]. In the latter case, all Fe(II) formed had been
found to get reoxidized back to Fe(III). In contrast, in dried solutions of the alkylresorcinols, the resulting Fe(II) was not
reoxidized upon drying in air; moreover, it was in fact found to be dominating in the dried solid (see Table 13.1). These
ﬁndingspointtosigniﬁcantlystrongerreducingand/orbinding(coordinating)powerofalkylresorcinolsortheiroxidation
products as compared to those of auxin.
The aforementioned examples unambiguously imply that some microbial autoinducers can be abiotically oxidized by soil
Fe(III) in moderately acidic media, which is of ecological signiﬁcance with regard to microbial signaling. An oxidation process
involvingaparticularmolecularsignalisverylikelytoexcludethelatterfromanysignalingpathways,whichisequalto“message
undelivery”,directlyaffectingmicrobialautoregulationand,generally,intercellularcommunicationinthemicrobialconsortium.
M€ ossbauer spectroscopy has been applied to microbial biomineralization studies in a few recent reports. For the
anaerobic alkaliphilic dissimilatory Fe(III)-reducing bacterium Geoalkalibacter ferrihydriticus, reduction of amorphous ferric
hydroxide(AFH),coupledtoacetateoxidation[56,57],ledtotheformationofsideriteFeCO3(atlowAFHconcentrations)
andpoorly(under[AFH] 0.07M)orbettercrystallizedmagneticallyorderedphases(at[AFH]above0.07M).Theanalysis
of M€ ossbauer spectra usinghyperﬁne ﬁeld distributions demonstratedthat thedistribution with a lower isomershift value
(d 0.3mms
 1) could be attributed to cations Fe
3þ located in A-positions of magnetite Fe3O4 and in both positions of
maghemiteg-Fe2O3whilethatwithalargeisomershiftvalue(d 0.6mms
 1)couldbeattributedtocationsFe
2.5þlocatedin
the B-positions of magnetite [57]. It was also shown that anthraquinone-2,6-disulfonate (quinone, an additional “electron
shuttle”) added to the bacterial cultivation medium resulted in a more intensive AFH reduction, increasing the relative
content of Fe3O4 and siderite [57]. The intensity of the magnetically split sextet increased with an increase in the quinone
concentration up to Cq  0.05gl
 1; remaining unchanged up to Cq¼0.3gl
 1. The relaxation character of the M€ ossbauer
spectra became more pronounced for Cq 0.4gl
 1, reﬂecting a reduction in the superparamagnetic particle size.
Using temperature-dependent M€ ossbauer measurements (at 4.5–300K), a similar AFH reduction was reported [58]
by a binary bacterial culture including, besides G. ferrihydriticus, also the non-Fe(III)-reducing alkaliphilic bacterium
Anaerobacillus alkalilacustre (in the presence of mannitol as the only substrate). The reduction process takes place due to
the growth of the former bacterium that utilizes the metabolic products formed by the latter that fermented mannitol.
Fe(III) mineral characterization was reported using M€ ossbauer spectroscopy and X-ray diffraction for minerals
formed in cell suspensions of Acidovorax sp. BoFeN1, a nitrate-reducing, Fe(II)-oxidizing bacterium [59]. Lepidocrocite
(g-FeOOH) (90%), which also forms after Fe(II) chemical oxidation by dissolved O2, and goethite (a-FeOOH) (10%)
were produced at pH 7.0 in the absence of strongly complexing ligands. Higher pH, increasing concentrations of
carbonate or humic acids promoted goethite formation and caused little or no changes in Fe(II) oxidation rates;
phosphate resulted in the formation of unidentiﬁable Fe(III) solids and notably slowed Fe(II) oxidation rates. Fe(III)
mineralogy due to bacterial Fe(II) oxidation thus seems to be strongly inﬂuenced by the solution chemistry.
UsingM€ ossbauerspectroscopy,threepositionsoftrivalentironwithnonoverlappingrangesofDEQwererevealedin
bacterialferrihydritenanoparticles,producedbythebacteriumKlebsiellaoxytocainthecourseofbiomineralizationofiron
salt solutionsfrom anaturalmedium, aftersample heating [60].Theﬁtofthesespectra andinterpretation ofresultsseem
to be doubtful, as the authors did not take into account a complicated iron core structure in bacterial ferritin and a core
size variation while relating their results to merely two structural differences in ferrihydrite.
In the magnetotactic bacterium Magnetospirillum gryphiswaldense,M€ ossbauer spectroscopic measurements allowed a
mechanism to be proposed for initial magnetite formation via membrane-bound ferritin and an Fe(II) species at the
cytoplasmic membrane [61]. The iron required for magnetite biomineralization is released directly at the membrane
invagination pit interface without iron ﬂux via the cytoplasm. This might imply distinct transport pathways for Fe3O4
formation and biochemical utilization of iron.
13.3 PLANTS
Although M€ ossbauer spectroscopy is capable of selectively characterizing Fe-containing chemical species, there have
been relatively few M€ ossbauer spectroscopic studies of iron in intact plant tissues. This is mainly because of the special
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sample requirements for obtaining an adequate M€ ossbauer spectrum. The biggest constraint is a very low iron content in
plants (and a low natural abundance of 57Fe). In addition, for the observation of the M€ ossbauer effect, the sample should
be in a solid state.
Despite these limitations, the technique has been applied in the past to characterize the forms of iron occurring in
different plants [62–65]. More recently, a detailed study of iron uptake and translocation in rice [66] grown in anaerobic
57FeCl2-enriched nutrient solutions showed primarily the presence of Fe(III) hydrous oxide components precipitated on
the root cell wall (ferrihydrite and/or lepidocrocite). No evidence of Fe(II) was found in the leaf tissue, the spectra were
characteristic of Fe(III) present in ferritin and in other complexed forms, not further identiﬁed by the authors. Iron
biomineralization was also observed in a perennial grass grown in extreme acidic environment with a high content of
metals [67,68]. In this case, the M€ ossbauer spectral analysis indicated that iron accumulated in this plant mainly as jarosite
and ferrihydrite (ferritin). Jarosite accumulated in roots and rhizomes, while ferritin was detected in all the structures.
Iron is an essential nutrient for plants and crucial for a variety of cell functions. In most soils, iron is not readily
available for plants due to the low solubility of iron oxyhydroxides at the soil pH. For this reason, plants have evolved
different strategies for iron uptake. Nongraminaceous plants follow strategy I that starts with reduction of iron chelates
at the outer surface of the plasma membrane [65,69]. The plasma membrane-bound enzyme, ferric reductase oxidase 2,
was shown to accept Fe(III) chelates and use cytoplasmic reducing equivalents (FADH2
1 or NADPH
2) to reduce them to
Fe(II) chelate [70] that releases iron due to its much lower stability, and the ferrous ions are taken up by a divalent cation
transporter. The reduction rate is increased under iron deﬁciency and is also accompanied by an increased proton
release [69]. In contrast, graminaceous monocots can produce phytosiderophores—speciﬁc, low molecular weight Fe
(III)-binding polydentate organic ligands—which solubilize iron and make it available for absorption (strategy II iron
uptake mechanism), that was earlier analyzed in [65].
Inabsorbingdifferentspecies,suchasFe(III)orFe(II),boththecellmembraneandthecellwallplayanimportantrole.
The complex network of cell walls within the whole plant organism is called the apoplast. It promotes the contact of cells
with the environment and forms an internal space for the nonphysiologicalaccumulation ofionic and uncharged particles.
After the iron is taken up through the membranes, it enters the cytoplasm, that builds a continuous network called
symplast, through microscopic channels between the cells. The targets of iron assimilation are different enzymes and
structures. Among these, heme proteins, iron–sulfur proteins and phytoferritin should be mentioned.
Roots of Fe-sufﬁcient cucumber (Cucumis sativus) were grown in hydroponic culture in unbuffered, modiﬁed
Hoagland solution containing 10mM 57FeðIIIÞ citrate [71–73]. The M€ ossbauer spectrum (Fig. 13.3a), recorded at
T¼80K, of the iron-sufﬁcient cucumber root grown with 10mM 57FeðIIIÞ citrate, shows an envelope of wide
symmetrical quadrupole doublet that can represent several Fe(III) microenvironments. Basing on the spectral
components assigned in the M€ ossbauer studies of plants [62,63,66,67], the spectra were ﬁtted with three symmetrical
doublets. The main component denoted by Fe(III)A represented an iron species in an octahedral coordination with
d¼0.50mms
 1, DEQ¼0.44mms
 1, and its relative area (S) 44%. The Fe(III)B component had d¼0.50mms
 1,
DEQ¼0.80mms
 1,a n dS¼35%. The third component, Fe(III)C (S¼21%), had d¼0.50mms
 1, DEQ¼1.22mms
 1
[73]. The M€ ossbauer spectrum of the freeze-dried cucumber root (Fig. 13.3b) [74] recorded at 4.2K exhibited a  70%
magneticallysplitsubspectrum,whileoneofthethreedoubletcomponents,existingathighertemperatures,disappeared.
At 1.5K, almost all species were magnetically ordered (Fig. 13.3c). The remaining paramagnetic species represented by
the quadrupole doublet could be transformed into magnetically split spectrum by applying 5T external magnetic ﬁeld
(Fig. 13.3d). The M€ ossbauer parameters obtained from the ﬁt in the case of the iron-sufﬁcient cucumber show that the
major component in the roots is a high-spin Fe(III) in octahedral coordination (Fe(III)A) possibly resulting from Fe(III)–
carboxylate complexes. These carboxylate complexes may include Fe(III)–organic acid and Fe(III)–amino acid species
inside the cell and Fe(III)–pectates in the apoplast. The M€ ossbauer parameters of the Fe(III)B component are in good
agreement with those reported for ferrihydrite in ferritin found in several plant tissues, for example, in pea roots [63], or
in rice [66]. The third doublet with the highest quadrupole splitting (Fe(III)C) can represent sulfate–hydroxide containing
Fe(III) species. According to its characteristic M€ ossbauer parameters, it can be attributed to jarosite [67,75] or its
analogous compound (MFe3(OH)6(SO4)2,M ¼K
þ,H 3O
þ,N a
þ, ...). It should be noted that another explanation of
several quadrupole doublets required for the best ﬁt of M€ ossbauer spectra of ferritin iron cores will be considered
further in Section 13.6.
However, it was not possible (not even with the help of the low-temperature measurements) to identify
unequivocally which compounds are represented by Fe(III)B and Fe(III)C, since the magnetic ordering temperatures
11,5-Dihydro ﬂavin adenine dinucleotide.
2Reduced form of nicotinamide dinucleotide phosphate.
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strongly depend on the particle sizes and crystallinity of the Fe(III) aggregates and are in strong correlation with the
stoichiometry of these compounds [63,72,76]. The magnetic properties of hydrous ferric oxides formed via bio-
mineralizationprocesses (as in the case of the iron-storage proteinferritin) also strongly depend on its composition [76].
The high PO4
3  ratio and the incorporation of organic ions such as citrate can lead to an amorphous structure and to a
decreaseintheantiferromagneticorderingtemperature(<4K).ConsideringthattheironuptakeinstrategyI-typeplants
isaccompaniedbyasigniﬁcantproton releaseandthatahighamountofsulfateionsispresentinthenutrient solution,the
formation of sulfate–hydroxide containing Fe(III) species with various stoichiometry can be favored in the cell wall. These
ﬁndings support that the magnetically split subspectra at 4.2 and 1.5K can be attributed to Fe(III) hydroxosulfates and
hydrous ferric oxides, respectively. However, the interpretation of the magnetically split subspectrum for one
superparamagnetic Fe-rich phase, such as ferritin with a small number of Fe atoms in the clusters, probably containing
other ligands such as PO4
3 ,S O 4
2 , and organic acids, cannot be entirely excluded. The paramagnetic component, which
can be transformed to magnetically split spectrum by applying 5T external magnetic ﬁeld at 1.5K, supports the presence
of ferric carboxylates, since the parameters of the quadrupole doublet (d¼0.5mms
 1, DEQ¼0.6mms
 1), presented in
Fig. 13.3b,c at 4.2 and 1.5K, correspond to those of the Fe(III)A component.
Although cucumber belongs to strategy I group, no Fe(II) could be detected when enough iron was available for the
plant, which is in good agreement with the previous M€ ossbauer results. This can be explained by the high relative amount
ofFe(III)presentintheroottissuesofiron-sufﬁcientplants(suppressingthesmallcontributionofthepossibleFe(II)inthe
M€ ossbauer spectrum). Three main types of iron-bearing species were suggested (sulfate–hydroxide containing ferric
species in the apoplast, hydrous ferric oxides possibly present as ferritininside the cell, and Fe(III) carboxylate complexes
both in the symplast and apoplast) to be formed naturally in the roots of cucumber grown in unbuffered Fe(III)–citrate
nutrient solution.
Cucumbers were grown in iron-deﬁcient nutrient solutions and supplied with 57FeðIIIÞ citrate at different
concentrations (10, 50, 100, and 500mM) for 30min and at 500mM for different time intervals (30, 60, 90, 180min,
and 24h) only before harvest. M€ ossbauer spectra of the cucumber roots taken after iron supply (T¼80K) are shown in
Fig. 13.4 [73,77]. The M€ ossbauer spectra of iron-deﬁcient cucumber roots supplied with 500mM 57FeðIIIÞ citrate for
30min could be decomposed similar to the iron-sufﬁcient samples, but in this case, an Fe(II) component could also be
found besides the Fe(III)A and Fe(III)C components (Fe(III)B did not appear in this case). The relative amounts of the
different iron species depended on the duration of iron supply (Table 13.2) [73]: the Fe(II) showed a signiﬁcant decrease
with the iron treatment, while the relative amount of the total Fe(III) increased. Application of different iron
concentrations during iron supply in 30-min time interval did not change the components that can be assigned to
FIGURE 13.3
M€ ossbauer spectra of iron-
sufﬁcient cucumber roots grown
in 10mM
57FeðIIIÞ-citrate-
containing nutrient solution
recorded at (a) T¼80K; (b)
T¼4.2K;(c)T¼1.5K;(d)T¼1.5K
applying 5T external magnetic
ﬁeld perpendicular to the
propagation of the g-ray.
(Adapted from Refs. 72,73.)
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the M€ ossbauer spectra of iron-deﬁcient plants supplied with 500mM 57FeðIIIÞ citrate. As can be seen from Fig. 13.4, the
relative amount of the detected Fe(II) showed a correlation with the concentration of the iron present in the nutrient
solution (Table 13.2). With increasing the amount of Fe(III) citrate, the amount of the reduced iron increased as well.
The fact that iron(II) was clearly detected by M€ ossbauer spectroscopy gives a direct evidence for the iron uptake
mechanism of strategy I. As the time of the iron treatment increased, the reductive capacity was decreasing because of
theincreasedamountofironalreadytakenupbytheroot[73].AccordingtotheM€ ossbauer parametersoftheFe(II), one
can see that it formed a hexaaquo complex [52] that might be the primary hydrated product of the ferric chelate
reductaseenzyme,accumulatedintheapoplastandnotattachedtoanyofthecellwallcomponents.Atthesametime,the
increase in the Fe(III)A component, representing iron both attached to the apoplast and taken up inside the cell, could be
observed. The ferritin-like component (denoted by Fe(III)B) was absolutely not detectable, which means this duration of
FIGURE 13.4
M€ ossbauer spectra (recorded at
T¼80K) of iron-deﬁcient
cucumber roots, supplied with
500mM
57FeðIIIÞ citrate for
different time periods, as
indicated in the Figure (a) [77],
and supplied with different
57FeðIIIÞ citrate concentrations, as
indicated in the Figure, for
30min (b) [73].
TABLE 13.2 M€ ossbauer Parameters of the Iron Components Found in the Iron Deﬁcient Cucumber Roots that
were Supplied with 500mM
57FeðIIIÞ Citrate for Different Time Intervals and with Different Amounts
of
57FeðIIIÞ Citrate for 30min [73]
Fe(II) Component Fe(III)A Component Fe(III)C Component
Sample
d1
e
(mms
 1)
DEQ1
e
(mms
 1)S 1
f (%)
d2
e
(mms
 1)
DEQ2
e
(mms
 1)S 2
f (%)
d3
e
(mms
 1)
DEQ3
e
(mms
 1)S 3
b (%)
Different time intervals during iron supply
30min 1.35 3.19 48 0.49 0.46 32 0.52 1.11 20
60min 1.31 3.05 23 0.46 0.44 60 0.45 1.15 17
90min 1.30 3.19 23 0.50 0.50 69 0.44 1.14 9
180min 1.35 3.17 15 0.50 0.48 81 0.50 1.14 4
24h 1.37 3.23 6 0.51 0.52 91 0.47 1.12 3
Different iron concentrations during iron supply
10
 5M 1.31 3.22 13 0.43 0.50 87 – – –
5 10
 5M 1.35 3.15 23 0.52 0.55 72 0.50 1.23 5
10
 4M 1.36 2.96 16 0.51 0.51 71 0.43 1.09 13
5 10
 4M 1.35 3.19 48 0.49 0.46 32 0.52 1.11 20
aSD 0.05mms
 1.
bRelative SD 5%.
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iron supply was insufﬁcient for producing the iron-storage protein. The accumulation of the iron/sulfate–hydroxide
component was possibly also not favored in this case, since Fe(III)C showed a decreasing tendency.
Similar results were shown by different iron concentrations applied during iron supply but more information could
be obtained about the mechanism of the reduction and the iron uptake. The relatively low amount of Fe(II) in the case of
the lowest applied 57FeðIIIÞ citrate concentration (see Fig. 13.4) can be explained by a very fast uptake and reoxidation
process. If more Fe(III) was available, the Fe(II)/Fe(III) ratio was shown to increase. Consequently, the accumulation of Fe
(II) in the apoplast was favored because of limited uptake and/or reoxidation processes. Comparing the total iron
concentration in the root with the amount reducible in 30min [73], it can be assumed that the reduction rate was high
enough to potentially reduce all Fe accumulated in the apoplast. Concerning that the uptake rate of Fe(II) is limited, this
might result in the accumulation of Fe(II) outside the plasma membrane.
13.4 ENZYMES
Many excellent applications of M€ ossbauer spectroscopy to heme and nonheme iron-containing metalloproteins were
reviewed in earlier reports (Section 13.1). A more recent “forum” article by Krebs et al. [78] should be mentioned. With
anintroduction to the technique,it then focuses onrecent developments pertainingto the applicationof 57Fe M€ ossbauer
spectroscopy in biochemistry, includingthe rapid freeze-quench method in conjunctionwith M€ ossbauer spectroscopy to
monitor changes at the Fe-containing active site during a biochemical reaction. Nowadays, annually there appear
numerous publications on such fascinating topics involving M€ ossbauer spectroscopy (often accompanied by other
techniques). A few representative examples brieﬂy considered below give a general view of its capabilities.
Iron–sulfur clusters are versatile electron transfer cofactors, which are ubiquitous in many metalloenzymes. In the
Bacillus subtilis, redox regulator (Fnr) that controls genes of the anaerobic metabolism in response to low oxygen tension,
an unusual structure for the oxygen-sensing [4Fe-4S]
2þ cluster was detected by a combination of genetic experiments
with UV–visible and M€ ossbauer spectroscopy [79]. Asp-141 wasidentiﬁed as the fourth iron–sulfur cluster ligand besides
three Cys residues.
In the oxygen-tolerant [NiFe] hydrogenase from the hyperthermophilic bacterium Aquifex aeolicus, three iron–sulfur
clusterswereidentiﬁedintheir usual redox states,a[3Fe-4S] and two [4Fe-4S],butalsoauniquehigh-potential statewas
found[80].Onthebasisof 57Fe M€ ossbauerspectroscopy,thishigh-potentialformwasattributedtoasuperoxidizedstate
of the [4Fe-4S] center proximal to the [NiFe] site. The unique environment of this cluster, characterized by a surplus
cysteine coordination, is able to tune the redox potentials and make it compliant with the [4Fe-4S]
3þ state. It is actually
the ﬁrst example of a biological [4Fe-4S] center that physiologically switches between 3þ,2 þ, and 1þ oxidation states
within a very small potential range.
Nonheme Fe is a conservative component of the Q-type photosynthetic reaction centers but its function remains
unknown. Using M€ ossbauer spectroscopy, it was shown [81] that in Rhodospirillum rubrum the nonheme Fe exists mostly
inaferrous low-spinstate.ThebindingofCd
2þions inthevicinityofthequinone–Fecomplex changed thehigh-spinstate
of the nonheme Fe into a low-spin one characterized by hyperﬁne parameters similar to those obtained for the nonheme
Fe low-spin state in untreated reaction centers, as conﬁrmed by M€ ossbauer measurements.
A homologue of the ferric uptake regulator (Fur) in M. gryphiswaldense was identiﬁed and analyzed in [82]. A fur
deletion mutant of M. gryphiswaldense biomineralized fewer and slightly smaller magnetite crystals than did the wild type.
Althoughthetotalcellularironaccumulationofthemutantwasdecreasedowingtoreducedmagnetitebiomineralization,
it exhibited an increased level of free intracellular iron, which was bound mostly to a ferritin-like metabolite that was
found signiﬁcantly increased in M€ ossbauer spectra of the mutant.
The rapid-quench method [78] was used in Ref. 83 to analyze the mechanism of a bacterial phenylalanine
hydroxylase, a mononuclear nonheme iron protein that uses tetrahydropterin as the source of the two electrons
needed to activate O2 for the hydroxylation of phenylalanine to tyrosine. M€ ossbauer spectra of samples prepared by
freeze-quenching the reaction of the complex enzyme–57FeðIIÞ–phenylalanine–6-methyltetrahydropterin with O2
revealed the accumulation of an intermediate at short reaction times (20–100ms). The M€ ossbauer parameters of
the intermediate (d¼0.28mms
 1, DEQ¼1.26mms
 1) suggested it to be a high-spin Fe(IV) complex similar to those
that have previously been detected in the reactions of other mononuclear Fe(II) hydroxylases.
Low-temperature molecular dynamics simulations of cytochrome c oxidase were used in Ref. 84 to predict an
experimentally observable M€ ossbauer spectral width. Predicted lineshapes were used to model Lorentzian doublets,
with which published cytochrome c oxidase M€ ossbauer spectra were simulated. Molecular dynamics-imposed
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constraints to spectral lineshapes allowed useful information to be obtained, for example, the presence of multiple
chemical species in the binuclear center of cytochrome c oxidase. Molecular dynamics-based predictions were found to
be in good agreement with published experimental spectra [84], showing promise for a renewed interest for application
of this approach in bioenergetics.
13.5 HEMOGLOBIN
Hemoglobin is the iron-containing oxygen-transport heme protein. Vertebrate hemoglobins are tetramers consisting of
two pairs of nonidentical protein chains (for review see Refs. 85,86). Human and animal adult hemoglobins consist of two
a-subunits and two b-subunits. Each subunit binds heme (iron protoporphyrin IX complex) that is the active site of
hemoglobin. Heme Fe(II) reversibly binds an oxygen molecule to realize protein function. Myoglobin, an oxygen-storage
heme protein, is similar to b-chains.
Owing to the important role of the heme iron electronic structure in the process of reversible oxygen binding,
M€ ossbauer spectroscopy of hemoglobins was related to the studies of the heme iron electronic structure variations in
relation to the heme iron stereochemistry. These studies were based on some features of M€ ossbauer spectra of
hemoglobins. It was observed that M€ ossbauer spectra of tetrameric oxyhemoglobin had a non-Lorentzian line shape in
the liquid nitrogen temperature region [87–90]. This asymmetry was better ﬁtted using a superposition of two
quadrupole doublets. It was supposed that two quadrupole doublets may be a result of the heme iron electronic
structure nonequivalence in a- and b-subunits of oxyhemoglobin. Further analysis of M€ ossbauer spectra of oxy-, deoxy-,
and carboxyhemoglobins [90,91] as well as theoretical quantum chemical calculations of quadrupole splitting for the
deoxyheme models in different subunits [92–94] demonstrated the necessity of taking into account the heme iron
electronicstructurenonequivalenceina-andb-subunitsoftetramericoxy-anddeoxyhemoglobins.Acomparativestudy
of human, rabbit, and pig oxyhemoglobins with different molecular structure and functions was carried out using
M€ ossbauer spectroscopy with a high velocity resolution [95]. M€ ossbauer spectra of human, rabbit, and pig oxy-
hemoglobins measured at 90K and presented in 1024 channels (Fig. 13.5a–c) were ﬁtted with and without taking into
account the heme iron electronic structure nonequivalence in a- and b-subunits. In both cases of spectra ﬁts, small
variations of hyperﬁne parameters were observed (Fig. 13.5d–f). Small differences in quadrupole splitting values of high
and low oxygen-afﬁnity human adult deoxyhemoglobin encapsulated in wet silica gel were observed in Ref. 96. However,
this result was obtained using M€ ossbauer spectroscopy with a low velocity resolution (in 256 channels); therefore, the
estimated error of 0.02mms
 1 for quadrupole splitting (i.e., probably the error of the ﬁt) was less than the real
instrumental error which means that the obtained differences may be doubtful.
A number of M€ ossbauer studies were related to the analysis of the effect of external factors on hemoglobin.
Investigation of oxyhemoglobin radiolysis by g-rays and electrons and microwave heating was reviewed in Ref. 97. Some
differences were shown in the processes of oxyhemoglobin radiolysis related to the type of radiation, its energy, and
irradiation dose. The study of conformational changes in methemoglobin and metmyoglobin by low temperature X-ray
irradiation was carried out using M€ ossbauer spectroscopy in Refs. 98,99. M€ ossbauer spectra showed a reduction of high-
spin Fe(III) by thermalized electrons and a production of a metastable low-spin Fe(II) myoglobin and hemoglobin
complexes where H2O was still bound at the sixth coordination.
AcomparativeM€ ossbauerstudyoftheeffectofphenylhydrazineonnormaladultandneonatalredbloodcellswascarried
out in Ref. 100. Although the same total amount of oxidized hemoglobin was found in both cells, a well-deﬁned oxidation
product of hemoglobin was demonstrated by M€ ossbauer spectra only in neonatal cells. This oxidation product was not
methemoglobin but a trivalent, high-spin iron compound. Further hemoglobin oxidation by acetylphenylhydrazine was used
for diagnostic tests on the basis of M€ ossbauer spectroscopy [101–104]. It was shown that red blood cells of patients affected
bybreastcanceraremoresensitivetothedenaturingactionofacetylphenylhydrazine,hencetheformationtimeofhemin,one
ofthelastoxidationproducts,issigniﬁcantlyshortertheninnormalsubjects.Theexperimentsshoweddifferencesduringiron
oxidation between breast cancer patients and healthy persons. Different amounts of hemin, after the same incubation time,
can discriminate between samples collected from people suffering from cancer and a healthy population.
Human hemoglobin oxidation with Fe(III)-heme formation as a result of the vanadyl ion effect was observed using
M€ ossbauer spectroscopy [105]. Partial oxidation of rat hemoglobin after 70 days of rats feeding with cerium chloridewas
detected by M€ ossbauer spectroscopy [106]. An attempt to study hemoglobin from patients with diabetes was done in
Ref. 107. However, poor statistical rates, alow signal-to-noise ratio, and a low velocity resolutionin these studies did not
permit the authors to extract more detailed and exact information.
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FIGURE 13.5
M€ ossbauer spectra of normal human adult (a), rabbit (b), and pig (c) oxyhemoglobins measured at 90K in 4096
channels and presented in 1024 channels (components are the results of the best ﬁt: 1—a-subunits, 2—b-subunits,
3—carboxyhemoglobin) and differences of M€ ossbauer hyperﬁne parameters for normal human adult (Î), rabbit
(^), and pig (&) oxyhemoglobins at T¼90K (approximation with one quadrupole doublet (d) and with two
quadrupole doublets: for a-subunits (e) and for b-subunits (f); indicated errors are instrumental errors for hyperﬁne
parameters evaluated for the spectra presented in 1024 channels or calculated errors obtained during the spectra
ﬁtting if these errors exceeded instrumental errors) [95].
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Recently, measurement of high velocity resolution M€ ossbauer spectra of oxyhemoglobins from patients with
multiple myeloma and chronic myeloleukemia was carried out, and small variations of hyperﬁne parameters in
comparison with normal human adult oxyhemoglobin were revealed [108,109].
13.6 FERRITIN AND HEMOSIDERIN
It is well known that iron in living systems is stored in ferritin and hemosiderin. A number of reviews have been published
in the recent years, summarizing the present knowledge about ferritin and hemosiderin [110] and the mineralization
process leading to the formation of the iron core [111].
Bauminger and Harrison reviewed studies of the process of iron core formation in human and horse spleen ferritins
using M€ ossbauer spectroscopy. It was demonstrated that iron deposition within ferrihydrite core in human and horse
spleen ferritin started with Fe(II) oxidation. This process was associated with ferroxidase center of H-chains. Further, an
Fe(III) compound and Fe(III) m-oxo-bridged dimers in ferroxidase centers of H-chains were found, which were
intermediate compounds in the process of iron oxyhydroxide core formation in horse spleen ferritin. The steps leading
to ferrihydrite core formation in human L- and H-ferritins were also identiﬁed and transfer between ferritin molecules
was established [112].
To obtain information about peculiarities of the iron core structure, a number of M€ ossbauer investigations were
undertakenusingapplied largemagnetic ﬁelds and low temperatures [113–115]. Theinﬂuenceofthe environment onthe
ironcoreformationwasinvestigatedinbacteriagrownindifferentsolutions(FeSO4,ZnSO4,TbCl3)[116]andapoferritin
obtained using D2Oo rH 2O solution [117]. Another M€ ossbauer study was undertaken to determine whether or not the
iron core formation depends on the oxidant type [118]. Chua-anusorn et al. studied horse spleen apoferritin
reconstituted at various temperatures with different numbers of iron atoms per protein shell [119].
M€ ossbauer spectra of ferritin and hemosiderin from the heart of patients with b-thalassemia/hemoglobin E were
obtained in Ref. 120. It was suggested that the iron cores had structures based on the mineral ferrihydrite and were
superparamagnetic with a mean blocking temperature of 34K. The hemosiderin particles had a very poor crystalline
structure.
Ferritin contains the polynuclear hydrous ferric oxide core, while iron–polysaccharide complexes modeling ferritin
consist of the b-FeOOH core inside the polysaccharide shell instead of the protein shell. These complexes are of
particularinterestbecause they are used orbeing developed asdrugs for iron-deﬁciency anemia treatment [121]. Among
them there are iron–dextrin, iron–dextran, iron–polymaltose, and other iron–polysaccharide complexes. Some of these
ferritin models were recently studied using M€ ossbauer spectroscopy [122–129]. M€ ossbauer spectra of some iron–
polysaccharide complexes measured by Funk et al. [123] demonstrated different superparamagnetic behavior and the
necessity of several paramagnetic and/or magnetic components for an adequate ﬁt of the spectra. Recently, Oshtrakh et
al. carried out a series of comparative studies of small variations in the hyperﬁne parameters in human liver ferritin and
various developed and commercial iron–dextran complexes (IDC) using M€ ossbauer spectroscopy with a high velocity
resolutionandspectrapresentationin512channels[122,124–127].Smallvariationsofquadrupolesplittingwerefoundat
87K for various IDC and ferritin in frozen solutions and lyophilized forms.
To get a better insight into the issue, M€ ossbauer spectroscopy with a high velocity resolution was used for a
comparative study of human liver ferritin and commercial medicines Imferon (iron–dextran complex), Maltofer, and
Ferrum Lek (iron–polymaltose complexes) [128,129]. M€ ossbauer spectra of ferritin and its models were measured at
295K and presented in 4096 or 2048 channels (Fig. 13.6a–d). The rough ﬁtting of these spectra using one quadrupole
split doublet (homogeneous model) demonstrated small differences of hyperﬁne parameters (Fig. 13.6e). It was further
observed that the necessary number of quadrupole doublets (heterogeneous model) for the best ﬁt was different for
ferritinanditsmodels.Forinstance,threedoubletsforImferon,fourdoubletsforferritin,andﬁve doubletsforMaltofer
and Ferrum Lek were necessary to get the best ﬁt of the spectra measured at 295K. These differences may be related to
structural and/or size variations in the iron cores of the materials studied. The obtained results indicated that the iron
core structure in human ferritin and its models is more complicated than it was believed and consists of several regions
with structural variations. It was supposed that these regions can be related, for instance, to surface and several internal
regions or to the presence of different crystallites.
Papaefthymiou outlined possible directions of future M€ ossbauer studies in the most recent review [130]. Among
them there is a study on magnetic properties that up to now reported about differences in ferritin particles behavior. It is
not clear yet whether iron storage conditions and the iron core structure inﬂuenced the magnetic properties of ferritin.
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A further development in the ﬁeld of M€ ossbauer spectra ﬁtting and analysis is expected regarding the explanation of
applicability of either continuous distributions of quadrupole splitting and hyperﬁne ﬁeld or a superposition of discrete
quadrupole doubletsandmagnetic sextets withmodels ofmultidomain and multilayer structures ofthe ferritin iron core.
Inthiscase,applicationofM€ ossbauer spectroscopywithahighvelocityresolutionmaybeusedbecauseitleadstoalower
instrumental error in the determination of hyperﬁne parameters (this allows small variations of hyperﬁne parameters to
be distinguished) as well as to a more reliable ﬁtting of complicated M€ ossbauer spectra (see reviews [32,34–39, 128]).
13.7 TISSUES
M€ ossbauer studies of tissues containing iron-storage proteins are more complex mainly because of a low iron content in
comparison with that in isolated ferritin and hemosiderin. In the ﬁrst comparative study of puriﬁed human liver ferritin,
chicken liver and spleen tissues carried out by Oshtrakh et al. [127,131–133], small differences in M€ ossbauer parameters
were observed at 295K. First, M€ ossbauer spectra were measured with a high velocity resolution in 4096 channels and
presented in 512 channels. Variations of M€ ossbauer parameters indicated small differences in the iron electronic
structure and the iron core structure of the iron-storage proteins. To increase the accuracy and decrease the
instrumental error in evaluating the hyperﬁne parameters, M€ ossbauer spectra of chicken liver and spleen tissues
were measured with a high velocity resolution at 295K and presented in 1024 channels with ﬁtting using a superposition
of two quadrupole doublets within the heterogeneous model (see Fig. 13.7a and b) [133]. Differences in M€ ossbauer
parameters for chicken liver and spleen are clearly seenin Fig. 13.7c–e and indicatethe presence ofstructural differences
in the proteins’ iron cores in these tissues.
The possible role of iron in Parkinson’s, Alzheimer’s, and progressive supranuclear palsy diseases was also studied
using M€ ossbauer spectroscopy. M€ ossbauer studies demonstrated that the most of iron in the brain including three brain
tissues substantia nigra, globus pallidus, and hippocampus was ferritin-like iron [134,135]. The amount of ferritin molecules
FIGURE 13.6
M€ ossbauer spectra of human liver ferritin (a), Imferon (b), Maltofer (c), and Ferrum Lek (d) measured at T¼295K
with a high velocity resolution and presented in 2048 channels (a, b, d) and in 4096 channels (c), indicated
components are the results of the best ﬁt; and relationship between the spectral hyperﬁne parameters for
Imferon (&), Maltofer (~), Ferrum Lek ( ), and human liver ferritin (^) obtained using one quadrupole
doublet ﬁt (e) [129].
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in Alzheimer’s tissues was found to be higher than in control samples, whereas the total amount of iron was the same. It
wassupposedthateitherironcoresinAlzheimer’ssamplesweresmallerthaninthecontrolsamplesoragreatamountof
hemosiderin occurs in pathological tissues [136]. The presence of up to 8% of nonferritin-like iron in parkinsonian
substantia nigra or possible slight differences in the composition of the ferritin-like iron cores in parkinsonian substantia
nigra were supposed [137]. All M€ ossbauer spectra measured at 300 and 90K looked like asymmetric doublets that were
ﬁtted using two singlets with the same area and different widths. To assess this asymmetry, the ratio of singlet widths was
used referred to as the asymmetry coefﬁcient [138]. However, this approach has no physical meaning. Moreover, there
are a number of studies in which asymmetrical M€ ossbauer spectra of ferritin were ﬁtted using a superposition of several
quadrupole doublets [128,129,133].
On the other hand, there are studies presenting an increase of iron concentration in parkinsonian tissues, so this
problemremainscontroversial[139,140].Suchironincreasewasassociatedwithneuromelanin,supposedtobethemain
iron-storage compound in substantia nigra neurons. It was believed that a larger cluster size demonstrated by M€ ossbauer
spectroscopy in iron-loaded neuromelanin in comparison with iron-depleted neuromelanin and intact nigral tissue
conﬁrmed that additional iron was added to existing iron clusters in neuromelanin.
FIGURE 13.7
M€ ossbauer spectra of chicken liver (a) and spleen (b) tissues measured at 295K and presented in 1024 channels and
differences of M€ ossbauer hyperﬁne parameters for normal human liver ferritin (^), chicken liver (&), and spleen
(Î) tissues obtained by ﬁtting with one (c) and two (d and e) quadrupole doublets [133].
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M€ ossbauer study of b-thalassemia/hemoglobin E heart tissue from patients who had received no transfusion and
chelation therapy was carried out in Ref. 120. Preliminary results of normal and lymphoid leukemia chicken liver and
spleen tissue study using M€ ossbauer spectroscopy with a high velocity resolution were obtained in Ref. 132. It was
observed that M€ ossbauer hyperﬁne parameters of liver and spleen samples demonstrated small changes between the
corresponding normal and pathological tissues.
13.8 PHARMACEUTICAL PRODUCTS
Various compounds containing M€ ossbauer isotopes are developed and used in pharmacy. Some diorganotin(IV)
compounds with cytotoxic activity against human adenocarcinoma HeLa cells were studied using
119Sn M€ ossbauer
spectroscopy by Ronconi et al. [141]. Xanthopoulou et al. studied organotin(IV) complexes with heterocyclic thioamides
with antitumor activity using 119Sn M€ ossbauer spectroscopy [142]. In addition, some recent studies of tin compounds
using 119Sn M€ ossbauer spectroscopy can be mentioned [143–146]. Gold compounds are also used in pharmacy.
Therefore,
197Au M€ ossbauer spectroscopy was used for the characterization of such compounds. The 197Au M€ ossbauer
spectrum ofseleno-auranoﬁn (SeAF), ananalogue of auranoﬁn (AF), the orally active antiarthritic gold drug in clinical use,
exhibited an asymmetric quadrupole doublet that may be a result of a residual sample texture [147].
Iron-containing pharmaceutical compounds are used and developed as anticancer and antibiotic drugs as well as for
treatment of iron deﬁciency. For instance, M€ ossbauer spectroscopy was used for studying iron complexes with
anticancer antibiotics such as anthracyclines [148], adenosine derivatives [149], and cyclin-dependent kinase inhibitors
[150]. Sharaby analyzed iron complexes of hexachlorocyclodiphosph(V)azanes of sulfaguanidine (H4L) with antimicrobial
activity [151]. Recently, some iron-containing complexes with antituberculosis activity were studied using M€ ossbauer
spectroscopy [152,153].
A number of ferric and ferrous compounds are used and developed for treatment of iron-deﬁciency anemia. The
results of M€ ossbauer studies of ferric complexes with various polysaccharides modeling ferritin [122–129] were
considered above. Complex of Fe(III) with protein succinylate was studied in Ref. 154. Recently, a characterization of the
iron state in iron–polygalacturonate complex that may be used for iron supplementation was made by Fodor et al. [155].
One ferric and two ferrous compounds in the studied complexes were found. Various vitamins and dietary supplements
contain ferrous compounds such as ferrous fumarate, ferrous sulfate, ferrous gluconate, and some others. The studies of
the iron in ferrous gluconate demonstrated the presence of a minor ferric compound in addition to ferrous gluconate;
moreover, it was shown that Fe
2þ in both ferrous gluconate and Ascofer occupied two [156] or three [157] distinct
sites. Further studies of vitamins and dietary supplements containing ferrous fumarate, ferrous sulfate, and ferrous
chelates were carried out using M€ ossbauer spectroscopy in Refs 127,158–160. It was found that vitamins and dietary
supplements with ferrous fumarate contained minor ferric and ferrous impurities, while those with ferrous sulfate
contained minor ferric impurity. In contrast, vitamin and dietary supplement with ferrous iron chelates contained large
amount of ferric compounds. Then these studies were continued by measuring M€ ossbauer spectra with a high velocity
resolution [161–163]. The applied experimental technique and the results obtained may be useful and important for
controlling the iron state and impurity level in iron-containing medicaments.
13.9 CONCLUSIONS
A brief review of various applications of M€ ossbauer spectroscopy for biological and biomedical studies demonstrated a
high potential of this technique in analyzing various biological and pharmaceutical species containing M€ ossbauer isotopes.
The results obtained are very useful for understanding biological functions of iron-containing biomolecules, the role of
iron in the living processes as well as in approaches to understand pathological changes in the living systems, organs,
tissues, and biomolecules. It may probably be useful for further development of diagnostically important tests based on
M€ ossbauer spectroscopy. However, this requires improving the quality of M€ ossbauer spectrometers and spectra
measurements. In particular, M€ ossbauer spectroscopy with a high velocity resolution may be one of further develop-
ments of the technique that allows high-quality M€ ossbauer spectra to be measured, that would be important for
biomedical and biological analyses.
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